Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
Saved in:
Main Authors: | , , , |
---|---|
Format: | Clinical Trial |
Language: | English |
Published: |
2014
|
Online Access: | http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3509 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
id |
th-cmuir.6653943832-3509 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-35092014-08-30T02:34:58Z Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer Thongprasert S. Phromwas N. Atikachi B. Jiemsripong K. 2014-08-30T02:34:58Z 2014-08-30T02:34:58Z 1994 Clinical Trial 0284-186X 7917373 http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3509 eng |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
language |
English |
format |
Clinical Trial |
author |
Thongprasert S. Phromwas N. Atikachi B. Jiemsripong K. |
spellingShingle |
Thongprasert S. Phromwas N. Atikachi B. Jiemsripong K. Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
author_facet |
Thongprasert S. Phromwas N. Atikachi B. Jiemsripong K. |
author_sort |
Thongprasert S. |
title |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
title_short |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
title_full |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
title_fullStr |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
title_full_unstemmed |
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
title_sort |
phase ii study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer |
publishDate |
2014 |
url |
http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3509 |
_version_ |
1681420061641801728 |